About Cetuximab
            
            Class: | Monoclonal antibody (EGFR inhibitor)  
Use: | Treatment of metastatic colorectal cancer (mCRC) in combination with chemotherapy, and treatment of squamous cell carcinoma of the head and neck (SCCHN) either as monotherapy or in combination with radiation therapy.  
Adult dose: | Initial dose of 400 mg/m² administered as a single intravenous infusion, followed by weekly doses of 250 mg/m².  
Pediatric dose: | Safety and efficacy have not been established in pediatric patients; not recomme
         
        
            
                
                
                    
                        Drug Class
                    
                    Monoclonal antibody (EGFR inhibitor)
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of metastatic colorectal cancer (mCRC) in combination with chemotherapy, and treatment of squamous cell carcinoma of the head and neck (SCCHN) either as monotherapy or in combination with radiation therapy.
                 
                
                
                    
                        Storage Requirements
                    
                    Store refrigerated at 2°C to 8°C (36°F to 46°F). Do not freeze. Protect from light.
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Merck KgaA, GERMANY
                    
                    
                    Package Size
                    50ml Vial
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 1349.50
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        Initial dose of 400 mg/m² administered as a single intravenous infusion, followed by weekly doses of 250 mg/m².
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy have not been established in pediatric patients; not recommended for use in this population.
                    
                 
                
                
                    
                        Side Effects
                    
                    Common side effects include rash, diarrhea, nausea, vomiting, fatigue, and infusion-related reactions.
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to cetuximab or any component of the formulation; history of severe infusion reactions.
         
        
        
            
                Important Warnings
            
            Risk of severe infusion reactions; monitor patients closely during and after infusion. Potential for dermatologic toxicities; may require dose adjustments. Risk of hypomagnesemia and electrolyte abnormalities.
         
        
        
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.